Amann Benedikt, Grunze Heinz, Vieta Eduard, Trimble Michael
Hospital Benito Menni, Dr. Antoni Pujadas 38, 08830 Sant Boi, Barcelona, Spain.
Clin EEG Neurosci. 2007 Apr;38(2):116-23. doi: 10.1177/155005940703800214.
This paper will discuss different definitions of the term "mood stabilizer" and highlight in detail the antiepileptic drugs carbamazepine, valproate and lamotrigine with respect to their relative strengths in stabilizing mood in bipolar patients. These drugs are heterogeneous in their mechanisms of action and in their efficacy to stabilize patients with epilepsy and the various mood states in bipolar disorder. Lamotrigine has obtained approval in several countries for the indication of preventing bipolar depressive episodes, which raises the question of differential efficacy of other antiepileptic drugs as mood stabilizers in the prevention of either depressive or hypo-/manic episodes. A Medline Search to 2006 was conducted for controlled acute and maintenance studies of the three scientifically and clinically most established antiepileptic drugs carbamazepine, valproate and lamotrigine. The medications discussed in this review only partly fulfill definitions of a mood stabilizer, and we suggest that future research should focus on combined treatment strategies.
本文将讨论“心境稳定剂”这一术语的不同定义,并详细阐述抗癫痫药物卡马西平、丙戊酸盐和拉莫三嗪在双相情感障碍患者心境稳定方面的相对优势。这些药物在作用机制以及稳定癫痫患者和双相情感障碍各种心境状态的疗效方面存在差异。拉莫三嗪已在多个国家获批用于预防双相抑郁发作,这引发了关于其他抗癫痫药物作为心境稳定剂在预防抑郁或轻躁狂/躁狂发作方面疗效差异的问题。对截至2006年的Medline进行检索,以查找关于三种科学和临床应用最广泛的抗癫痫药物卡马西平、丙戊酸盐和拉莫三嗪的对照急性和维持性研究。本综述中讨论的药物仅部分符合心境稳定剂的定义,我们建议未来的研究应聚焦于联合治疗策略。